"Unseeable chronic conditions like migraine, arthritis, and diabetes put a limit on living your best life. We study these conditions so we can bring new treatments to the world. You can help and potentially find help."

During the past decade, Clinvest Research LLC conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 55 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 32 clinical trials were completed. i.e. 58.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinvest Research LLC" #1 sponsor was "Eli Lilly and Company" with 30 trials, followed by "Pfizer" with 18 trials sponsored, "Cady, Roger, M.D." with 12 trials sponsored, "Allergan" with 9 trials sponsored and "Clinvest" with 9 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinvest Research LLC" #1 collaborator was "GlaxoSmithKline" with 6 trials as a collaborator, "Allergan" with 3 trials as a collaborator, "Clinvest" with 3 trials as a collaborator, "Clinvest Research, LLC" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Clinvest Research LLC" are "Migraine" (38 trials), "Chronic Migraine" (9 trials), "Type 2 Diabetes" (7 trials), "Migraine Headache" (5 trials) and "Migraine With Aura" (5 trials). Many other conditions were trialed in "Clinvest Research LLC" in a lesser frequency.

Most popular intervention types in "Clinvest Research LLC" are "Drug" (114 trials), "Device" (9 trials), "Biological" (8 trials), "Other" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "Tirzepatide" (7 trials), "Rimegepant" (5 trials), "Atogepant" (4 trials) and "Dulaglutide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinvest Research LLC" are 126 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinvest Research LLC". undefined are not yet recruiting, 28 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Clinvest Research LLC, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Clinvest Research LLC, 1 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 6 trials that are defined as “Not Applicable".